BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17998677)

  • 1. Radiation injury to the spinal cord in head and neck cancers: does field arrangement have a role.
    Anusheel M; Prabhakar R; Mohanti BK
    J Cancer Res Ther; 2006; 2(2):65-7. PubMed ID: 17998677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal cord dose is higher than expected in head and neck radiation.
    Allison R; Vaughan J; Thurber A; Rajecki M; Vongtama V; Barry T
    Med Dosim; 1999; 24(2):135-9. PubMed ID: 10379511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord dose from standard head and neck irradiation: implications for three-dimensional treatment planning.
    Martel MK; Eisbruch A; Lawrence TS; Fraass BA; Ten Haken RK; Lichter AS
    Radiother Oncol; 1998 May; 47(2):185-9. PubMed ID: 9683367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose sparing of brainstem and spinal cord for re-irradiating recurrent head and neck cancer with intensity-modulated radiotherapy.
    Chen CC; Lee CC; Mah D; Sharma R; Landau E; Garg M; Wu A
    Med Dosim; 2011; 36(1):21-7. PubMed ID: 20202815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of radiation myelitis of the cervical spinal cord at doses of 5500 cGy or greater.
    Jeremic B; Djuric L; Mijatovic L
    Cancer; 1991 Nov; 68(10):2138-41. PubMed ID: 1913452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of myelitis after irradiation of the cervical spinal cord.
    Marcus RB; Million RR
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):3-8. PubMed ID: 2380091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intensity-modulated radiotherapy of head and neck cancers. Dose constraint for spinal cord and brachial plexus].
    Boisselier P; Racadot S; Thariat J; Graff P; Pointreau Y
    Cancer Radiother; 2016 Oct; 20(6-7):459-66. PubMed ID: 27614529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
    Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
    Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repair of radiation damage and radiation injury to the spinal cord.
    Schultheiss TE
    Adv Exp Med Biol; 2012; 760():89-100. PubMed ID: 23281515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation tolerance of the cervical spinal cord.
    Kim YH; Fayos JV
    Radiology; 1981 May; 139(2):473-8. PubMed ID: 7220892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation tolerance of the cervical spinal cord.
    McCunniff AJ; Liang MJ
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):675-8. PubMed ID: 2921166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo evaluation of tissue inhomogeneity effects in the treatment of the head and neck.
    Wang L; Yorke E; Chui CS
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1339-49. PubMed ID: 11483347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lhermitte's sign following head and neck radiotherapy.
    Lewanski CR; Sinclair JA; Stewart JS
    Clin Oncol (R Coll Radiol); 2000; 12(2):98-103. PubMed ID: 10853747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying risk factors for L'Hermitte's sign after IMRT for head and neck cancer.
    Laidley HM; Noble DJ; Barnett GC; Forman JR; Bates AM; Benson RJ; Jefferies SJ; Jena R; Burnet NG
    Radiat Oncol; 2018 May; 13(1):84. PubMed ID: 29728105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiation-induced myelopathy].
    Kasperek S; Motta E
    Neurol Neurochir Pol; 1985; 19(2):144-8. PubMed ID: 3900781
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiomyelopathy after conventionally fractionated and hyperfractionated radiotherapy--experimental data and clinical consequences.
    Niewald M; Feldmann U; Feiden W; Kiessling M; Berberich W; Lehmann W; Abel U; Staut W; Büscher-Rolles E; Walter K; Nieder C; Nestle U; Deinzer M; Schnabel K
    Front Radiat Ther Oncol; 1999; 33():293-304. PubMed ID: 10549499
    [No Abstract]   [Full Text] [Related]  

  • 17. Planning and delivering high doses to targets surrounding the spinal cord at the lower neck and upper mediastinal levels: static beam-segmentation technique executed with a multileaf collimator.
    De Neve W; De Wagter C; De Jaeger K; Thienpont M; Colle C; Derycke S; Schelfhout J
    Radiother Oncol; 1996 Sep; 40(3):271-9. PubMed ID: 8940755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beam number on organ-at-risk sparing in dynamic multileaf collimator delivery of intensity modulated radiation therapy.
    Popple RA; Fiveash JB; Brezovich IA
    Med Phys; 2007 Oct; 34(10):3752-9. PubMed ID: 17985620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and MRI discordance in a case of delayed radiation myelopathy.
    Maddison P; Southern P; Johnson M
    J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):563-4. PubMed ID: 11183040
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cervical myelopathies caused by radiation. Report of 3 cases].
    Figini HA; Grosz D
    Prensa Med Argent; 1970 Nov; 57(37):1755-8. PubMed ID: 5503135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.